1. Home
  2. PRAX vs LAD Comparison

PRAX vs LAD Comparison

Compare PRAX & LAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$295.56

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Logo Lithia Motors Inc.

LAD

Lithia Motors Inc.

HOLD

Current Price

$253.47

Market Cap

8.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRAX
LAD
Founded
2015
1946
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Retail-Auto Dealers and Gas Stations
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
8.2B
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
PRAX
LAD
Price
$295.56
$253.47
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
11
Target Price
$572.13
$380.27
AVG Volume (30 Days)
298.8K
318.9K
Earning Date
05-01-2026
04-22-2026
Dividend Yield
N/A
0.91%
EPS Growth
N/A
9.01
EPS
N/A
32.32
Revenue
N/A
$11,821,400,000.00
Revenue This Year
N/A
$5.02
Revenue Next Year
$6,395.88
$4.30
P/E Ratio
N/A
$7.54
Revenue Growth
N/A
17.20
52 Week Low
$26.70
$239.78
52 Week High
$354.87
$360.56

Technical Indicators

Market Signals
Indicator
PRAX
LAD
Relative Strength Index (RSI) 42.98 33.81
Support Level $290.36 N/A
Resistance Level $322.32 $344.10
Average True Range (ATR) 16.81 8.04
MACD -2.42 0.49
Stochastic Oscillator 26.09 38.20

Price Performance

Historical Comparison
PRAX
LAD

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

About LAD Lithia Motors Inc.

Lithia Motors is a retailer of new and used vehicles and related services. The company offers over 50 brands of vehicles at nearly 500 stores globally across the US, Canada, and UK. The company has expanded largely through the acquisition of dealerships in smaller regional markets but now seeks to grow in any part of the US and we expect more deals over time in the US and, at times, abroad. Annual revenue in 2024 was $36.2 billion and we see over $50 billion possible in a few years. The US was 78% of 2024 revenue and the UK second at 19%, due to the 2024 Pendragon acquisition. In 2024, new vehicle sales were about 49% of total revenue. Lithia was founded in 1946, went public in 1996, and is the largest US auto dealer. It is based in Medford, Oregon.

Share on Social Networks: